Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects-Reference-Cited by-同舟云学术

Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects

Published:2022-04-17 Issue:20 Volume:11 Page:3820-3836
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Miller Ian S.¹²^ORCID,Khan Sonja³,Shiels Liam P.¹,Das Sudipto⁴,O' Farrell Alice C.¹,Connor Kate¹,Lafferty Adam¹,Moran Bruce⁵,Isella Claudio⁶,Loadman Paul⁷,Conroy Emer⁵,Cohrs Susan⁸,Schibli Roger⁸,Kerbel Robert S.⁹,Gallagher William M.⁵,Marangoni Elisabetta¹⁰,Bennett Kathleen¹¹,O' Connor Darran P.⁴,Dwyer Róisín M.³^ORCID,Byrne Annette T.¹²⁵

Affiliation:

1. Department of Physiology and Medical Physics Royal College of Surgeons in Ireland, St Stephens Green Dublin Ireland

2. National Preclinical Imaging Centre Royal College of Surgeons in Ireland, St Stephens Green Dublin Ireland

3. Discipline of Surgery The Lambe Institute for Translational Research, National University of Ireland Galway Galway Ireland

4. School of Pharmacy and Biomedical Sciences Royal College of Surgeons in Ireland, St Stepehen's Green Dublin Ireland

5. UCD School of Bimolecular and Biomedical Science University College Dublin Dublin Ireland

6. Institute for Cancer Research and Treatment University of Turin Turin Italy

7. School of Pharmacy and Medical Sciences, University of Bradford Bradford UK

8. Center for Radiopharmaceutical Sciences Paul Scherrer Institute Villigen Switzerland

9. Sunnybrook Research Institute University of Toronto Ontario Canada

10. Translational Research Department Institute Curie, PSL Research University Paris France

11. Division of Population Health Science Royal College of Surgeons in Ireland Dublin Ireland

Funder

European Commission

Irish Cancer Society

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4756

Reference41 articles.

1. Aspirin and colorectal cancer: the promise of precision chemoprevention

2. COX-2 involvement in breast cancer metastasis to bone

3. The role of cyclooxygenase-2 in breast cancer: review

4. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin

5. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer